Jinghua Pharmaceutical Group Co., Ltd. (SHE:002349)
China · Delayed Price · Currency is CNY 6.85
-0.15 (-2.14%)
Nov 13, 2026, 3:04 PM CST
SHE:002349 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Equivalents | 727.78 | 854.92 | 1,014 | 921.76 | 933.27 | 651.59 |
Trading Asset Securities | 394.74 | 434.74 | 105.16 | 317.7 | 124.95 | 213.36 |
Cash & Short-Term Investments | 1,123 | 1,290 | 1,119 | 1,239 | 1,058 | 864.95 |
Cash Growth | -5.38% | 15.28% | -9.74% | 17.13% | 22.35% | 24.26% |
Accounts Receivable | 486.8 | 417.83 | 414.58 | 387.67 | 339.16 | 355.87 |
Other Receivables | 1.25 | 1.68 | 2.68 | 0.68 | 2.7 | 17.19 |
Receivables | 488.05 | 419.5 | 417.26 | 388.35 | 341.86 | 373.06 |
Inventory | 273.08 | 277.32 | 270.35 | 290.94 | 307.65 | 323.12 |
Other Current Assets | 38.77 | 40.61 | 37.95 | 67.06 | 21.31 | 33.93 |
Total Current Assets | 1,922 | 2,027 | 1,844 | 1,986 | 1,729 | 1,595 |
Property, Plant & Equipment | 542.18 | 565.16 | 616.38 | 663.36 | 708.42 | 1,169 |
Long-Term Investments | 742.24 | 497.65 | 356.99 | 40.02 | 46.97 | 20.99 |
Goodwill | 167.94 | 167.94 | 167.94 | 167.94 | 167.94 | 167.94 |
Other Intangible Assets | 57.12 | 58.68 | 60.52 | 62.53 | 65.06 | 123.24 |
Long-Term Deferred Tax Assets | 8.26 | 6.98 | 5.98 | 6.22 | 12.59 | 14.88 |
Long-Term Deferred Charges | - | - | - | - | - | 37.92 |
Other Long-Term Assets | 237.49 | 246.84 | 249.67 | 259.13 | 267.89 | 25.01 |
Total Assets | 3,678 | 3,570 | 3,302 | 3,185 | 3,042 | 3,198 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Accounts Payable | 123.71 | 155.4 | 148.44 | 141.94 | 139.61 | 213.06 |
Accrued Expenses | 55.6 | 133.43 | 115.71 | 123.65 | 140.77 | 107.69 |
Short-Term Debt | 11.31 | 1.68 | 10.43 | 20.92 | 21.03 | 68.78 |
Current Portion of Long-Term Debt | - | - | - | - | - | 120.16 |
Current Portion of Leases | 0.86 | 0.42 | 0.75 | 1.18 | 0.68 | 1.77 |
Current Income Taxes Payable | 21.55 | 6.74 | 11.16 | 13.6 | 12.04 | 7.95 |
Current Unearned Revenue | 7.83 | 12.22 | 11.44 | 13.6 | 45.1 | 30.43 |
Other Current Liabilities | 135.02 | 84.9 | 27.65 | 46.62 | 35.41 | 53.39 |
Total Current Liabilities | 355.88 | 394.79 | 325.58 | 361.51 | 394.63 | 603.24 |
Long-Term Leases | 1.68 | 1.68 | 0.2 | 0.43 | 0.91 | 3.88 |
Long-Term Unearned Revenue | 10.32 | 12.96 | 11.73 | 10.84 | 10.65 | 9.5 |
Long-Term Deferred Tax Liabilities | 10.89 | 9.48 | 7.15 | 7.96 | 12.02 | 11.93 |
Other Long-Term Liabilities | - | 2.23 | - | - | - | - |
Total Liabilities | 378.78 | 421.13 | 344.66 | 380.75 | 418.22 | 628.54 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Common Stock | 831.13 | 829.67 | 814.18 | 814.18 | 814.18 | 835.72 |
Additional Paid-In Capital | 842.91 | 823.47 | 769 | 769 | 905.92 | 1,017 |
Retained Earnings | 1,264 | 1,149 | 995.01 | 860.5 | 677.94 | 514.59 |
Treasury Stock | -59.17 | -55.49 | - | - | - | -132.2 |
Comprehensive Income & Other | 4.96 | 5.9 | 5.3 | 0.91 | 2.89 | 1.14 |
Total Common Equity | 2,884 | 2,753 | 2,583 | 2,445 | 2,401 | 2,236 |
Minority Interest | 414.99 | 396.5 | 373.63 | 359.67 | 222.77 | 333.72 |
Shareholders' Equity | 3,299 | 3,149 | 2,957 | 2,804 | 2,624 | 2,570 |
Total Liabilities & Equity | 3,678 | 3,570 | 3,302 | 3,185 | 3,042 | 3,198 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Total Debt | 13.85 | 3.77 | 11.38 | 22.54 | 22.62 | 194.59 |
Net Cash (Debt) | 1,109 | 1,286 | 1,107 | 1,217 | 1,036 | 670.36 |
Net Cash Growth | -6.49% | 16.12% | -9.00% | 17.51% | 54.48% | 34.21% |
Net Cash Per Share | 1.36 | 1.57 | 1.36 | 1.49 | 1.27 | 0.82 |
Filing Date Shares Outstanding | 814.3 | 827.42 | 814.18 | 814.18 | 814.18 | 814.18 |
Total Common Shares Outstanding | 814.3 | 827.42 | 814.18 | 814.18 | 814.18 | 814.18 |
Working Capital | 1,567 | 1,632 | 1,519 | 1,624 | 1,334 | 991.83 |
Book Value Per Share | 3.54 | 3.33 | 3.17 | 3.00 | 2.95 | 2.75 |
Tangible Book Value | 2,659 | 2,526 | 2,355 | 2,214 | 2,168 | 1,945 |
Tangible Book Value Per Share | 3.27 | 3.05 | 2.89 | 2.72 | 2.66 | 2.39 |
Buildings | - | 577.17 | 575 | 570.97 | 567.6 | 949.94 |
Machinery | - | 668.15 | 638.6 | 618.06 | 619.1 | 695.42 |
Construction In Progress | - | 27.07 | 53.57 | 69.42 | 61.51 | 59.36 |